98%
921
2 minutes
20
Oxidative stress contributes to tumourigenesis by altering gene expression. One accompanying modification, 8-oxoguanine (oG) can change RNA-RNA interactions via oG•A base pairing, but its regulatory roles remain elusive. Here, on the basis of oG-induced guanine-to-thymine (oG > T) variations featured in sequencing, we discovered widespread position-specific oGs in tumour microRNAs, preferentially oxidized towards 5' end seed regions (positions 2-8) with clustered sequence patterns and clinically associated with patients in lower-grade gliomas and liver hepatocellular carcinoma. We validated that oG at position 4 of miR-124 (4oG-miR-124) and 4oG-let-7 suppress lower-grade gliomas, whereas 3oG-miR-122 and 4oG-let-7 promote malignancy of liver hepatocellular carcinoma by redirecting the target transcriptome to oncogenic regulatory pathways. Stepwise oxidation from tumour-promoting 3oG-miR-122 to tumour-suppressing 2,3oG-miR-122 occurs and its specific modulation in mouse liver effectively attenuates diethylnitrosamine-induced hepatocarcinogenesis. These findings provide resources and insights into epitranscriptional oG regulation of microRNA functions, reprogrammed by redox changes, implicating its control for cancer treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/s41556-023-01209-6 | DOI Listing |
Acad Radiol
September 2025
Department of Radiology, The First Medical Center of Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing 100853, China (X.Y., X.M., J.Z., Y.Z., G.L., F.X., C.H., X.L.). Electronic address:
Rationale And Objectives: In depth comparison of imaging features and overall survival (OS) between IDH wild-type diffuse lower-grade glioma and glioblastoma (GB), providing precise guidance for early risk stratification and optimized clinical decision-making.
Materials And Methods: Retrospective inclusion of IDH wild-type glioma patients admitted between January 2017 and January 2024. Patients were classified into GB (histological and molecular) and lower-grade glioma not elsewhere classified (LGNEC) based on fifth edition of the Central Nervous System Tumor Classification Standards.
Neurooncol Adv
August 2025
Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Background: Patients with IDH-mutant gliomas often experience seizures that significantly affect their quality of life and outcome. Seizure activity may be the result of dysregulation of excitatory (glutamate, Glu) and inhibitory (gamma-aminobutyric acid, GABA) neurotransmitters in peritumoral tissue. A non-invasive measurement of Glu (in combination with glutamine, termed Glx) and GABA is feasible with proton magnetic resonance spectroscopy (H-MRS).
View Article and Find Full Text PDFAppl Biochem Biotechnol
September 2025
Department of Neurosurgery, Yantaishan Hospital Affiliated to Binzhou Medical University, No. 10087, Keji Avenue, Laishan District, Yantai, 264003, Shandong, China.
Fatty acid metabolism is critical for numerous biological processes involved in the pathogenesis of glioma. This study aimed to survey the role of ORMDL sphingolipid biosynthesis regulator 2 (ORMDL2) in fatty acid metabolism of glioma cells. The expression of ORMDL2 in glioma and its association with survival rate was detected using The Cancer Genome Atlas (TCGA) data and Kaplan-Meier survival curve.
View Article and Find Full Text PDFTransl Oncol
August 2025
Department of Neurosurgery, Fudan University Affiliated Huashan Hospital, Shanghai, China. Electronic address:
Glioma is one of the most aggressive and lethal brain tumors, with poor prognosis and limited treatment options. This study examined the function of CLEC18B in glioma development and its viability as a predictive biomarker. Pan-cancer research demonstrated that CLEC18B is dysregulated in several tumor types, with elevated expression associated with reduced overall survival (OS) and disease-specific survival (DSS) in patients with different malignancies, including glioma.
View Article and Find Full Text PDFCancer Res Commun
August 2025
Stanford University, Palo Alto, CA, United States.
Glioblastoma (GBM) is a highly vascularized, heterogeneous tumor, yet anti-angiogenic therapies have yielded limited survival benefits. The lack of validated predictive biomarkers for treatment response stratification remains a major challenge. Aminoacyl tRNA synthetase complex-interacting multicomplex proteins (AIMPs) 1/2/3 have been implicated in CNS diseases, but their roles in gliomas remain unexplored.
View Article and Find Full Text PDF